Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-004619
Filing Date
2015-06-19
Accepted
2015-06-19 17:50:55
Documents
1
Period of Report
2015-06-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4061815lapointe_soligenix.html 4  
1 OWNERSHIP DOCUMENT f4061815lapointe_soligenix.xml 4 3921
  Complete submission text file 0001213900-15-004619.txt   5665
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 83216 GAITHERSBURG MD 20883-3216
Business Address
LAPOINTE ANTHONY GREGG (Reporting) CIK: 0001331860 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 15943262